Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens Journal:Breast Cancer Research and Treatment | 2021 | ||
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens Journal:Breast Cancer Research and Treatment | 2021 | ||
Rate and correlates of self-stigma in adult patients with early psychosis Journal:Frontiers in Psychiatry | 13-Jul-2023 |